These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 14633302)

  • 41. Bioinorganic aspects of angiogenesis.
    D'Andrea LD; Romanelli A; Di Stasi R; Pedone C
    Dalton Trans; 2010 Sep; 39(33):7625-36. PubMed ID: 20535417
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Angiogenesis and current antiangiogenic strategies for the treatment of cancer.
    Oklu R; Walker TG; Wicky S; Hesketh R
    J Vasc Interv Radiol; 2010 Dec; 21(12):1791-805; quiz 1806. PubMed ID: 20980167
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The role of macrophage-derived IL-1 in induction and maintenance of angiogenesis.
    Carmi Y; Voronov E; Dotan S; Lahat N; Rahat MA; Fogel M; Huszar M; White MR; Dinarello CA; Apte RN
    J Immunol; 2009 Oct; 183(7):4705-14. PubMed ID: 19752225
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Angiogenesis in reproductive tissues.
    Findlay JK
    J Endocrinol; 1986 Dec; 111(3):357-66. PubMed ID: 2433380
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Metformin regulates ovarian angiogenesis and follicular development in a female polycystic ovary syndrome rat model.
    Di Pietro M; Parborell F; Irusta G; Pascuali N; Bas D; Bianchi MS; Tesone M; Abramovich D
    Endocrinology; 2015 Apr; 156(4):1453-63. PubMed ID: 25590243
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Targeting tumor micro-environment for design and development of novel anti-angiogenic agents arresting tumor growth.
    Gacche RN; Meshram RJ
    Prog Biophys Mol Biol; 2013 Nov; 113(2):333-54. PubMed ID: 24139944
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The role of angiogenesis in prostate development and the pathogenesis of prostate cancer.
    Hrouda D; Nicol DL; Gardiner RA
    Urol Res; 2003 Feb; 30(6):347-55. PubMed ID: 12599013
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Angiogenesis as a therapeutic target for obesity and metabolic diseases.
    Cao Y
    Chem Immunol Allergy; 2014; 99():170-9. PubMed ID: 24217609
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Angiogenesis and the role of the endothelial nicotinic acetylcholine receptor.
    Cooke JP
    Life Sci; 2007 May; 80(24-25):2347-51. PubMed ID: 17383685
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Angiogenic factors as potential drug target: efficacy and limitations of anti-angiogenic therapy.
    Gacche RN; Meshram RJ
    Biochim Biophys Acta; 2014 Aug; 1846(1):161-79. PubMed ID: 24836679
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mechanisms of Disease: angiogenesis in inflammatory diseases.
    Szekanecz Z; Koch AE
    Nat Clin Pract Rheumatol; 2007 Nov; 3(11):635-43. PubMed ID: 17968334
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Extracellular angiogenic growth factor interactions: an angiogenesis interactome survey.
    Rusnati M; Presta M
    Endothelium; 2006; 13(2):93-111. PubMed ID: 16728328
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Vascular and neuronal effects of VEGF in the nervous system: implications for neurological disorders.
    Carmeliet P; Storkebaum E
    Semin Cell Dev Biol; 2002 Feb; 13(1):39-53. PubMed ID: 11969370
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hemostatic complications of angiogenesis inhibitors in cancer patients.
    Elice F; Jacoub J; Rickles FR; Falanga A; Rodeghiero F
    Am J Hematol; 2008 Nov; 83(11):862-70. PubMed ID: 18819092
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Role of angiogenesis in inflammatory bowel disease.
    Koutroubakis IE; Tsiolakidou G; Karmiris K; Kouroumalis EA
    Inflamm Bowel Dis; 2006 Jun; 12(6):515-23. PubMed ID: 16775497
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Angiogenesis in normal and neoplastic ovaries.
    Ramakrishnan S; Subramanian IV; Yokoyama Y; Geller M
    Angiogenesis; 2005; 8(2):169-82. PubMed ID: 16211363
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Angiogenesis of prostate cancer and antiangiogenic therapy.
    Uehara H
    J Med Invest; 2003 Aug; 50(3-4):146-53. PubMed ID: 13678383
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antagonist antibodies to vascular endothelial growth factor receptor 2 (VEGFR-2) as anti-angiogenic agents.
    Falcon BL; Chintharlapalli S; Uhlik MT; Pytowski B
    Pharmacol Ther; 2016 Aug; 164():204-25. PubMed ID: 27288725
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The crucial role of vascular permeability factor/vascular endothelial growth factor in angiogenesis: a historical review.
    Ribatti D
    Br J Haematol; 2005 Feb; 128(3):303-9. PubMed ID: 15667531
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tumour angiogenesis: the relevance to surgeons.
    Atkin GK; Chopada A
    Ann R Coll Surg Engl; 2006 Oct; 88(6):525-9. PubMed ID: 17059709
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.